Ur24Technology
Private Company
Funding information not available
Overview
Ur24Technology is a commercial-stage medical device company addressing a significant unmet need in urinary care with its innovative TrueClr™ external catheter system. The FDA Class 1 device differentiates itself by being the first external system to actively empty the bladder for all patient populations, positioning it as a potential replacement for infection-prone internal catheters. With CMS reimbursement secured and products sold through authorized distributors, the company is focused on market penetration. Its value proposition centers on reducing CAUTIs, improving patient quality of life, and lowering healthcare costs associated with urinary incontinence and retention.
Technology Platform
Proprietary external urinary catheter system utilizing a gentle vacuum pump (aspirator) to actively empty the bladder. Features a latex-free, hypoallergenic, non-adhesive sleeve with a leak-proof design to prevent skin contact with urine.
Opportunities
Risk Factors
Competitive Landscape
Competes against two main categories: internal Foley catheters (dominant standard but cause CAUTIs) and traditional passive external catheters (prone to leakage and skin issues). TrueClr's active-drainage, leak-proof design is a first-in-class differentiator. Broader competitors include large urology/continence care companies (e.g., Coloplast, Hollister, BD, Teleflex) which could develop similar technology.